Paul Wang, M.D.

Rare Disease / Clinical Research

Seaside Therapeutics, Inc.

QC-verified· March 2026 PI on 3 trials

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Fragile X syndrome
Sex-chromosome anomaly syndrome

Clinical trials (3)

NCT01282268
NCT01325220
NCT01555333

Verify independently

ClinicalTrials.gov PI search for Paul Wang, M.D.

Other specialists for Fragile X syndrome

Peers ranked by clinical-trial PI role, publications, and verification quality.

Elizabeth Smith, PhD
Cincinnati Children's Hospital
Ohio
Anne Wheeler, PhD
RTI International
North Carolina
Flora Tassone
School of Medicine
Randi J Hagerman, M.D
Medical Investigation of Neurodevelopmental Disorders (MIND) Institute UCDH
CA
Dragana Protic
Clinical Pharmacology and Toxicology
Randi Hagerman, M.D
Medical Investigation of Neurodevelopmental Disorders Institute
CA
Anne Hoffmann
Rush University Medical Center
Barbara Bardoni
Institute of Molecular and Cellular Pharmacology

See all specialists for Fragile X syndrome →

← Back to specialists directory